Xiaoling Wu
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Genetic Neurodegenerative Diseases 2
- Co-authors
- Wei‐Feng Qu (2 shared papers)Duojiao Wu (2 shared papers)Ying–Hong Shi (2 shared papers)Jian Zhou (2 shared papers)Run Huang (2 shared papers)Jia Fan (2 shared papers)Zheng Tang (2 shared papers)Jun Gao (2 shared papers)
In The Last Decade
Xiaoling Wu
15 papers receiving 485 citations
Xiaoling Wu's Hit Papers
Peers
Comparison fields: 5 of 42
- Hepatology 84
- Cancer Research 100
- Immunology 91
- Oncology 99
- Cellular and Molecular Neuroscience 50
Countries citing papers authored by Xiaoling Wu
This map shows the geographic impact of Xiaoling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wu more than expected).
Fields of papers citing papers by Xiaoling Wu
This network shows the impact of papers produced by Xiaoling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wu. The network helps show where Xiaoling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor Hit paper breakdown → | 2023 | 271 |
| 2 | 2021 | 53 | |
| 3 | 2022 | 51 | |
| 4 | 2023 | 39 | |
| 5 | 2024 | 32 | |
| 6 | 2025 | 12 | |
| 7 | 2024 | 9 | |
| 8 | 2025 | 5 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 |
About Xiaoling Wu
Xiaoling Wu is a scholar working on Hepatology, Cellular and Molecular Neuroscience, Immunology, Oncology and Cancer Research, having authored 16 papers that have together received 487 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Genetic Neurodegenerative Diseases (2 papers), Immune cells in cancer (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Lipid metabolism and biosynthesis (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Hepatology (84 citations), Cancer Research (100 citations), Immunology (91 citations), Oncology (99 citations) and Cellular and Molecular Neuroscience (50 citations). Xiaoling Wu has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Wei‐Feng Qu, Duojiao Wu, Ying–Hong Shi, Jian Zhou, Run Huang, Jia Fan, Zheng Tang, Jun Gao, Wei‐Ren Liu and Yuan Fang. Their work appears in journals such as Hepatology International, Acta Neuropathologica, Signal Transduction and Targeted Therapy, Neuroscience Bulletin and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.